Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.
Clarivate Plc (NYSE: CLVT) is described as a leading global provider of transformative intelligence, with news that reflects its activities across Academia & Government, Intellectual Property and Life Sciences & Healthcare. Company announcements frequently highlight new AI-powered tools, analytical reports and customer adoptions that illustrate how Clarivate combines enriched data, analytics and workflow software.
Recent news includes the launch of the Web of Science Research Assistant, a generative AI-powered tool that helps researchers conduct natural-language searches, perform literature reviews and explore visualizations based on more than 120 years of publication and citation data. Clarivate also reports on studies such as the Pulse of the Library report, which surveys thousands of librarians worldwide about AI adoption, open science and budget pressures, and on the annual Highly Cited Researchers list, which recognizes researchers whose work has had broad influence based on Web of Science data.
In Intellectual Property, Clarivate issues updates on solutions like IPfolio and Derwent Patent Monitor, including customer selections by organizations such as Nissan Motor Co., Ltd. and FUJIFILM Holdings Corporation. These stories emphasize how IP management platforms and AI-enabled patent review tools support more efficient IP operations and collaboration between IP and R&D teams.
Life sciences and healthcare news often centers on Clarivate analyses such as the Drugs to Watch report and Companies to Watch reports, which identify emerging therapies and innovative companies using integrated, AI-enhanced datasets. Visitors to this news page can follow Clarivate’s product launches, research reports, customer case studies and investor-related announcements to understand how the company is applying data and AI across its core markets.
Clarivate Plc reported strong financial results for Q2 2022, with revenues of $686.6 million, up 54% year-over-year. Organic revenue growth was 4.8%. The company recorded a net income of $43.7 million, a significant turnaround from a net loss of $131.5 million in the same quarter last year. Adjusted EBITDA rose 45.2% to $274.4 million, and adjusted net income increased by 50.1%. However, cash flow from operations declined by $97.1 million to $164.6 million, primarily due to seasonality and one-time payments. CEO Jerre Stead announced retirement plans, effective end of August.
Clarivate Plc (NYSE: CLVT) has been chosen by the National Library Board of Singapore (NLB) to provide library software solutions through its Innovative division. This contract includes the Polaris Integrated Library System and Vega Discover applications, designed to enhance the library experience for both staff and patrons. The initiative aligns with NLB's Libraries and Archives Blueprint 2025, aimed at modernizing library services. Executive Chairman Jerre Stead emphasized Clarivate's commitment to innovation and improving library automation and discovery standards.
On July 27, 2022, Clarivate Plc (NYSE:CLVT) released a new Global Research Report from the Institute for Scientific Information, emphasizing the necessity to escalate ocean science research in response to challenges like microplastics pollution and climate change. The report shows a threefold increase in ocean science research output from 2000 to 2020, highlighting critical trends and collaboration gaps. It notes rapid growth in microplastics research since 2015 and shifting dominance from the U.S. to Mainland China in ocean research output.
Clarivate Plc (NYSE: CLVT) announced that in the 2023 Journal Citation Reports (JCR), all journals in the Web of Science Core Collection will receive a Journal Impact Factor (JIF). This expansion includes nearly 9,000 journals, enhancing transparency for quality journals, especially from the Global South. The JIF will now show one decimal place to emphasize additional metrics. The change reflects Clarivate's ongoing commitment to integrity in scholarly research and will be effective from June 2023.
Clarivate Plc (NYSE: CLVT) has announced that its MarkMonitor division is now the first and only foreign-owned domain name registrar licensed in Mainland China. This new service allows businesses to register various Top Level Domains including .com, .cn, and .net. The Chinese e-commerce market is projected to reach US$3.3 trillion by 2025, highlighting significant growth potential. Chief Product Officer Gordon Samson emphasized the importance of secure domain management amid increasing cyber threats, aiming to bolster brand protection for organizations operating in this dynamic region.
Clarivate Plc (NYSE:CLVT) has released a new report titled Extending the Human Lifespan, exploring advancements in anti-aging science and the development of potential drugs. The report highlights a significant rise in the global population aged 65 and older, creating a demand for solutions to enhance both lifespan and quality of life. Key findings include 139 ongoing trials for seven existing drugs that might extend lifespan, raising $1.95 billion for aging-related companies since 2020. However, there are concerns regarding gender disparities in aging research.
Clarivate Plc (NYSE:CLVT) announced the retirement of Jerre Stead as CEO, effective September 1, 2022, after three years of leadership during which the company nearly tripled in size. Jonathan Gear has been appointed as CEO-elect, starting July 11, 2022, with a strong background in technology and data services, previously serving as CFO of IHS Markit. Mr. Stead will transition to Non-Executive Chair of the Board, emphasizing the confidence in Mr. Gear to lead the company forward. Clarivate aims to position itself as a leading provider of innovative solutions.
Clarivate Plc (NYSE: CLVT) announced it will release its second quarter 2022 financial results on August 9, 2022, prior to market opening. The earnings report and financial details will be available on the investor website. A conference call and webcast to discuss the results will occur on the same day at 9:00 AM Eastern Time. Interested parties can join the call via a dedicated phone line or access the live webcast through the company’s investor relations site. A replay will be available for a limited time following the call.
Clarivate Plc (NYSE: CLVT) has been selected for the second consecutive time to provide citation data for the Australian Research Council's Excellence in Research for Australia (ERA) 2023. This initiative aims to evaluate research excellence across Australian universities. Utilizing The Web of Science™, Clarivate will support the ARC in assessing research quality through citation indicators and peer reviews. Clarivate has been involved with ERA since its inception in 2010, continually implementing improvements to enhance research evaluations.
Summary not available.